The numerous evidence that underline the complex action exerted by GPER up-regulation and activation in the progression of breast cancer will be summarized here, having also a look at the chance to consider it as a further biological target for innovative therapeutic strategies in breast tumor. The gene discussed is GPER1; the disease is breast neoplasm.